World Drug markets jan-Aug 1994

7 November 1994

The world market for pharmaceuticals (at retail prices) increased by a total of 5% in the year to August 1994 compared with the first eight months of 1993, to reach a value of $77.95 billion, according to the latest figures published by IMS International on the leading world markets.

The largest growth rates in the eight-month period were recorded by the USA and the UK, rising 8% each to a total of $31.76 billion and $3.57 billion respectively. Germany and the Netherlands both experienced growth of 6% during the period, to $8.70 billion and $1.11 billion respectively, while Spain advanced 4% to $2.54 billion and Belgium was up 3% to $1.03 billion.

Retail pharmacy sales in Canada and France both rose 2%, to $2.22 billion and $8.01 billion, while the market in Japan rose only 1% to $14.12 billion, as a result of the National Health Insurance price cuts imposed in April.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight